United Therapeutics (UTHR) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 11/03/21
United Therapeutics Corporation To Present At The Credit Suisse 30th Annual Healthcare ConferencePRNewsWire • 11/01/21
United Therapeutics Corporation To Report Third Quarter 2021 Financial Results Before The Market Opens On Wednesday, November 3, 2021PRNewsWire • 10/27/21
United Therapeutics' (UTHR) Tyvaso DPI NDA Gets CRL From FDA (Revised)Zacks Investment Research • 10/20/21
FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung DiseaseBenzinga • 10/18/21
United Therapeutics Provides an Update on the Progress of the Tyvaso DPI™ New Drug ApplicationPRNewsWire • 10/18/21
United Therapeutics Converts to a Public Benefit Corporation Following Shareholder ApprovalPRNewsWire • 09/30/21
United Therapeutics-MannKind's Formulated Tyvaso Shows Benefit In Pulmonary Hypertension PatientsBenzinga • 09/07/21
United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021PRNewsWire • 09/07/21
United Therapeutics (UTHR) Up 3.4% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 09/03/21
United Therapeutics Partners with Former NFL Player Devon Still and His Daughter Leah to Launch "Braving NeuroBLASToma" in Honor of Childhood Cancer Awareness MonthPRNewsWire • 08/25/21
United Therapeutics to Present Tyvaso DPI™ BREEZE Clinical Data at the European Respiratory Society International Congress 2021PRNewsWire • 08/24/21
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/04/21
United Therapeutics (UTHR) Q2 Earnings and Revenues Surpass EstimatesZacks Investment Research • 08/04/21